June 10, 2020 / 9:56 PM / 23 days ago

BRIEF-Eli Lilly Canada Presents New Data For Olumiant At Virtual European Congress Of Rheumatology

June 10 (Reuters) - Eli Lilly and Co:

* ELI LILLY CANADA - PRESENTED NEW DATA FOR OLUMIANT AT VIRTUAL EUROPEAN CONGRESS OF RHEUMATOLOGY

* ELI LILLY CANADA -AMONG PATIENTS WITH INADEQUATE RESPONSE TO MTX, 52% OF PATIENTS INITIALLY TREATED WITH OLUMIANT (+MTX) WERE IN SDAI LDA STATE AT WEEK 24

* ELI LILLY CANADA - STUDY FOUND OLUMIANT’S SAFETY PROFILE TO BE CONSISTENT AS PREVIOUSLY REPORTED, NO RISE IN RATES OF SAFETY TOPICS OF INTEREST Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below